AU5052999A - Human ccr-2 gene polymorphisms - Google Patents

Human ccr-2 gene polymorphisms

Info

Publication number
AU5052999A
AU5052999A AU50529/99A AU5052999A AU5052999A AU 5052999 A AU5052999 A AU 5052999A AU 50529/99 A AU50529/99 A AU 50529/99A AU 5052999 A AU5052999 A AU 5052999A AU 5052999 A AU5052999 A AU 5052999A
Authority
AU
Australia
Prior art keywords
gene polymorphisms
human ccr
ccr
human
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50529/99A
Inventor
Rakesh Anand
John Edward Norris Morten
John Craig Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816193.8A external-priority patent/GB9816193D0/en
Priority claimed from GBGB9901844.2A external-priority patent/GB9901844D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AU5052999A publication Critical patent/AU5052999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU50529/99A 1998-07-25 1999-07-20 Human ccr-2 gene polymorphisms Abandoned AU5052999A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9816193 1998-07-25
GBGB9816193.8A GB9816193D0 (en) 1998-07-25 1998-07-25 Chemical compounds
GB9901844 1999-01-28
GBGB9901844.2A GB9901844D0 (en) 1999-01-28 1999-01-28 Chemical compounds
PCT/GB1999/002341 WO2000006769A2 (en) 1998-07-25 1999-07-20 Human ccr-2 gene polymorphisms

Publications (1)

Publication Number Publication Date
AU5052999A true AU5052999A (en) 2000-02-21

Family

ID=26314110

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50529/99A Abandoned AU5052999A (en) 1998-07-25 1999-07-20 Human ccr-2 gene polymorphisms

Country Status (4)

Country Link
EP (1) EP1100963A2 (en)
JP (1) JP2002521063A (en)
AU (1) AU5052999A (en)
WO (1) WO2000006769A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004183D0 (en) * 2000-02-22 2000-04-12 Smithkline Beecham Plc New use
DE10049549A1 (en) 2000-10-06 2002-05-02 Markus Hecker Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40
JPWO2002079466A1 (en) 2001-03-30 2004-07-22 塩澤　俊一 Genomic DNA involved in rheumatoid arthritis, a method for diagnosing the same, a method for determining the possibility of developing the same, and a diagnostic kit for detecting them
US7306913B2 (en) 2002-12-20 2007-12-11 Applera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532570B2 (en) * 1994-01-13 2004-05-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Mammalian monocyte chemoattractant protein receptor
JPH09238688A (en) * 1996-03-11 1997-09-16 Takeda Chem Ind Ltd Production of human mcp-1 receptor protein and its use
JP2000508912A (en) * 1996-04-19 2000-07-18 スペクトラ バイオメディカル，インコーポレイテッド Correlating polymorphic forms with multiple phenotypes

Also Published As

Publication number Publication date
EP1100963A2 (en) 2001-05-23
WO2000006769A2 (en) 2000-02-10
JP2002521063A (en) 2002-07-16
WO2000006769A3 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
AU4787697A (en) Therapeutic gene
AU5430499A (en) Photobioreactor
AU9128798A (en) Genotyping of human cyp3a4
AU1878601A (en) Enzyme
AU3882997A (en) Human telomerase gene
EP1077996A4 (en) HUMAN EDG3sb GENE
AU2576100A (en) Novel enzyme
AU3388400A (en) Human glycosylation enzymes
AU3849999A (en) Endo-beta-n-acetylglucosaminidase gene
AUPQ262599A0 (en) Gene expression
AU6387000A (en) Serial analysis of genetic alterations
AU6271598A (en) Targeted modification of the ccr-5 gene
AU3178200A (en) Genetic analysis
AU1927699A (en) Nucleotide polymorphisms in soybean
AU6417799A (en) Matrix-remodeling genes
AU2732000A (en) Reverse gene therapy
AU5052999A (en) Human ccr-2 gene polymorphisms
AU2258601A (en) Ibd-related polymorphisms
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
AU1773501A (en) Human single nucleotide polymorphisms
AU3099200A (en) Novel human wnt gene
AU1873201A (en) Interferon-alpha induced gene
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AU4577099A (en) Human fast-1 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase